APC-Asef interaction can relieve the negative intramolecular regulation of Asef, which leads to aberrant migration in human CRC, suggesting that this interaction might be a potential target for the treatment of invasive migration in colorectal cancer. Here, ARHGEF4 is linked to colorectal carcinoma.